Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Bone Biologics Corp’s current trading price is -79.64% away from its 52-week high, while its distance from the 52-week low is 168.75%. The stock’s price range over this period has fluctuated between $0.80 and $10.56. The company, operating within the financial sector, had a trading volume of approximately 2.26 million for the day, which was noticeably lower than the average daily share volume of 4.85 million over the last 3 months.
In terms of market performance, Bone Biologics Corp had a fairly uneven. The highest value for the stock in the past year was $10.56 on 12/28/23, and the lowest value was recorded at $0.80 on 09/13/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Bone Biologics Corp (BBLG) has experienced a quarterly rise of 72.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.14M and boasts a workforce of 2 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.55, with a change in price of +0.59. Similarly, Bone Biologics Corp recorded 3,163,962 in trading volume during the last 100 days, posting a change of +37.38%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BBLG stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
BBLG Stock Stochastic Average
Today’s raw stochastic average for Bone Biologics Corp over the last 50 days is 39.13%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 81.33%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 75.93% and 78.60%, respectively.
BBLG Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -52.43%. However, over the past six months, we’ve seen a stronger performance of -2.27%. The price of BBLG fallen by 36.08% over the last 30 days. And in the last five days, it has surged by 168.75%.
